These DMS-based high-throughput metabolomics platforms have also been employed to investigate the AD-like pathology in the APP × PS1 transgenic mouse model by considering multiple biological matrices, namely serum [23], urine [24], brain [25], and other peripheral organs [26]. Here, APP is linked to Alzheimer disease.